MARKET

HOLX

HOLX

Hologic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

72.35
+1.94
+2.76%
After Hours: 72.94 +0.59 +0.82% 17:16 03/05 EST
OPEN
70.91
PREV CLOSE
70.41
HIGH
72.46
LOW
67.88
VOLUME
2.26M
TURNOVER
--
52 WEEK HIGH
85.00
52 WEEK LOW
26.49
MARKET CAP
18.64B
P/E (TTM)
13.72
1D
5D
1M
3M
1Y
5Y
Lateral Flow Assay Market Is Expected To Grow At A CAGR of 7.67% During 2020-2025
Mar 07, 2021 (AmericaNewsHour) -- The Global Lateral Flow Assay Market was valued at USD 4.81 billion in 2016 and is projected to reach USD 9.36 billion by...
AmericaNewsHour · 10h ago
Companion Diagnostics Market 2020 includes Attractiveness and Raw Material Analysis and Competitor Position Grid Analysis to 2025
Mar 07, 2021 (AmericaNewsHour) -- The Global Companion Diagnostics Market was valued at USD 2.03 billion in 2016 and is projected to reach USD 10.30 billion...
AmericaNewsHour · 10h ago
Global HPV Testing Market 2020 Key Trends, Sales Growth, Market Value-Chain and Forecast to 2025
Mar 07, 2021 (CDN Newswire via Comtex) -- The most recent report namely Global HPV Testing Market 2020 by Manufacturers, Regions, Type and Application,...
CDN Newswire · 10h ago
Global Healthcare-Acquired Infection Market 2020 Business Outlook with COVID-19 Scenario to 2025
Mar 07, 2021 (CDN Newswire via Comtex) -- The latest report entitled Global Healthcare-Acquired Infection Market 2020 by Company, Regions, Type and...
CDN Newswire · 13h ago
Global Cancer Biomarker market Size, Share, Value, and Competitive Landscape 2026
Mar 07, 2021 (Heraldkeepers) -- The research report includes specific segments by region (country), by company, by Type and by Application. This study...
Heraldkeepers · 19h ago
Myriad Genetics (MYGN) Collaborates to Advance Oncology Care
Zacks.com · 2d ago
Hologic Inc. stock outperforms competitors on strong trading day
Shares of Hologic Inc. advanced 2.76% to $72.35 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...
marketwatch.com · 2d ago
Top Ranked Growth Stocks to Buy for March 5th
Zacks.com · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HOLX. Analyze the recent business situations of Hologic through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HOLX stock price target is 89.08 with a high estimate of 106.00 and a low estimate of 80.00.
EPS
Institutional Holdings
Institutions: 877
Institutional Holdings: 254.10M
% Owned: 98.62%
Shares Outstanding: 257.66M
TypeInstitutionsShares
Increased
200
16.23M
New
146
717.08K
Decreased
224
17.74M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.35%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/President/Chief Executive Officer/Director
Stephen MacMillan
Chairman/President/Chief Executive Officer/Director
Stephen Macmillan
Chief Financial Officer
Karleen Oberton
Corporate Executive
Sanjay Prabhakaran
Corporate Executive
Kevin Thornal
Senior Vice President/Director of Human Resources
Allison Bebo
General Counsel
John Griffin
Corporate Executive
Jan Verstreken
Lead Director/Independent Director
Sally Crawford
Chief Accounting Officer
Benjamin Cohn
Vice President/IR Contact Officer
Michael Watts
Independent Director
Charles Dockendorff
Independent Director
Scott Garrett
Independent Director
Ludwig Hantson
Independent Director
Namal Nawana
Independent Director
Christiana Stamoulis
Independent Director
Amy Wendell
No Data
About HOLX
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Webull offers kinds of Hologic, Inc. stock information, including NASDAQ:HOLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HOLX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HOLX stock methods without spending real money on the virtual paper trading platform.